홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Acepromazine

HCID 6077
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
61-00-7
표준 SMILES
CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2
InChIKey
NOSIYYJFMPDDSA-UHFFFAOYSA-N
분자식
C19H22N2OS
평균 분자량
326.5 g/mol
단동위원소 질량
326.1452845

개요

Acepromazine is a member of the class of phenothiazines that is 10H-phenothiazine substituted by an acetyl group at position 2 and a 3-(dimethylamino)propyl group at position 10. It has a role as a phenothiazine antipsychotic drug. It is a member of phenothiazines, a tertiary amino compound, a methyl ketone and an aromatic ketone.

이름 및 식별자

우선 이름
Acepromazine
IUPAC
1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone
영어명
acepromazine
분자식
C19H22N2OS
분자량
326.46

이름 및 동의어

ACEPROMAZINEAcetylpromazineAcetopromazine61-00-7AcepromazinaAtravetAcezine 2Acepromazinum10-(3-Dimethylaminopropyl)phenothiazin-3-yl methyl ketoneConcentrat vo3410-(3-Dimethylaminopropyl)phenothiazine-3-ethyloneEthanone, 1-(10-(3-(dimethylamino)propyl)-10H-phenothiazin-2-yl)-
이름 더 보기
1522CBA 23051NotensilVetranquilAids013600Aids-013600Acetylperazine
54EJ303F0R1-(10-(3-(Dimethylamino)propyl)-10H-phenothiazin-2-yl)ethanoneEthanone, 1-[10-[3-(dimethylamino)propyl]-10H-phenothiazin-2-yl]-1-[10-(3-DIMETHYLAMINO-PROPYL)-10H-PHENOTHIAZIN-2-YL]-ETHANONEDTXSID1022552CHEBI:449321-{10-[3-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethanone1-{10-[3-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethan-1-one

데이터베이스 식별자

CAS
61-00-7
PubChem CID
6077
DTXSID
DTXSID1022552
ChEMBL
CHEMBL39560
ChEBI
CHEBI:44932
UNII
54EJ303F0R
EC Number
200-496-0
Nikkaji
J4.812G

물성

구조 계산 물성

XLogP
4.2
극성 표면적
48.9 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
4
회전 가능 결합 수
5
무거운 원자 수
23
형식 전하
0
복잡도
414

실험 및 물리화학적 성질

Drugs · 2건

DEA NFLIS-Drug Category -> Depressants and Tranquilizers

Pharmaceuticals -> Listed in ZINC15

Solubility9.80e-03 g/L
Animal Drugs · 2건

Pharmaceuticals -> UK Veterinary Medicines Directorate List

Pharmaceuticals -> Animal Drugs -> Approved in Taiwan

Melting Point · 2건

< 25 °C

< 25 °C

Physical DescriptionSolid
Collision Cross Section · 4건

176.6 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

169.77 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

160.5 Ų [M+H]+ [CCS Type: TW]

186.38 Ų [M+Na]+

물리화학적 성질

녹는점
25 °C · <25 °C
끓는 점
0.5 · bp0.5 220-240°
밀도
1.1075 · 1.1075 (rough estimate)
굴절률
1.595 · 1.5950 (estimate)
산도 계수 (pKa)
9.41 · 9.41±0.28(Predicted)
색상
오렌지 오일
수용성
16 mg/L · 16mg/L(25℃)

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P262, P264, P264+P265, P270, P271, P272, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P319, P321, P330, P332+P317, P333+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory Information · 2건

REACH registered substance: Acepromazine (EC: 200-496-0)

Ethanone, 1-10-3-(dimethylamino)propyl-10H-phenothiazin-2-yl-: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and CategoriesAcute Tox. 3 (100%)

안전 데이터

독성
LD50 intraperitoneal in mouse: 350mg/kg

화학 및 산업

약리 정보

ATC Code · 2건

N - Nervous system

QN - Nervous system

Pharmacodynamics · 1건

Acepromazine is one of the phenothiazine derivative psychotropic drugs. Acepromazine has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Acepromazine has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.

Mechanism of Action · 1건

Acepromazine acts as an antagonist (blocking agent) on different postsysnaptic receptors -on dopaminergic-receptors (subtypes D1, D2, D3 and D4 - different antipsychotic properties on productive and unproductive symptoms), on serotonergic-receptors (5-HT1 and 5-HT2, with anxiolytic, antidepressive and antiaggressive properties as well as an attenuation of extrapypramidal side-effects, but also leading to weight gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors (antisympathomimetic properties, lowering of blood pressure, reflex tachycardia, vertigo, sedation, hypersalivation and incontinence as well as sexual dysfunction, but may also attenuate pseudoparkinsonism - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate, sinus tachycardia, ECG-changes and loss of memory, but the anticholinergic action may attenuate extrapyramidal side-effects).

Biological Half-Life3 hours in horses.
MeSH Pharmacological Classification · 2건

Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.

Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME.

Cellular LocationsExtracellular

용도 및 제조

Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan

응용 분야

용도Sedative (veterinary).

상·하류 제품 정보

상류 원료

1-(2-아세틸페노티아진-10-일)에타논1-[10-(3-chloropropyl)-10H-phenothiazin-2-yl]ethan-1-one메틸페노티아진-10-일케톤디메틸아민3-클로로프로필(디메틸)아민2-아세틸페노티아진2-Bromothiophenol페노티아진

관련 반응

1건
반응 기록 만들기
HRID 1078539 반응식
HRID 1078539반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트